Dry Skin Coping Strategies
Dry skin is a common problem among GIST patients. There are many things that you can do to alleviate dry skin caused by GIST treatment. Keep reading for more info. Dry Skin Coping Strategies: Using [...]
Necrosis of the Jaw Coping Strategies
Necrosis of the jaw has been reported to occur in some patients receiving bisphophonate therapy. There have been several reports of possible drug interaction between sunitinib (Sutent) and bisphophonates that significantly increases the risk of necrosis [...]
Edema Coping Strategies
Between fifty to seventy percent of GIST patients participating in Gleevec clinical trials are reported to have edema according to the Life Raft Group survey (October, 2001) and www.gleevec.com. Edema can develop in different [...]
Mouth Sores – Coping Strategies
Mouth sores, or stomatitis as it is referred to in medical textbooks, can develop as a result of cancer treatment. There are many ways to help prevent and reduce the occurrence of mouth sores. How [...]
Increased Tearing – Epiphoria Coping Strategies
Increased tearing, or epiphoria, can be a side effect of your GIST treatment. There are a number of strategies to cope with increased tearing. Keep reading for more information. Here are a few strategies [...]
Hand and Foot Syndrome Coping Strategies
Hand and Foot Syndrome coping strategies. Although targeted cancer therapies are generally considered to have less side effects than traditional chemotherapy, the need to take these drugs for extended time periods (in many cases [...]
Muscle Cramps – Coping Strategies
Updated 2/9/2022 Muscle cramps can occur during cancer treatment, and it is a common side effect patients in our Patient Registry experience. GIST Treatments including Gleevec, Sutent, Stivarga, Qinlock and Ayvakit can cause a [...]
Stivarga becomes first FDA-approved third-line drug treatment for GIST
The Food and Drug Administration, in a much-anticipated announcement for Gastrointestinal Stromal Tumor patients, approved Bayer Pharmaceutical’s drug, Stivarga, for use as a third-line treatment for advanced GIST in February.
Lon Garber’s Excellent Adventure: facing Gollum, P.T. & Paul Simon with R2D2
Lon Garber It all began in Africa with a pain in my backside. My wife, Val, jokingly called it payback time since I’d been a pain in her backside for 37 years. The [...]
Sutent Treatment Use Trial Results
Patients with GIST who received sunitinib using a flexible dose approach to manage adverse events remained on treatment longer than those who received the strict dose/schedule and exhibited better clinical outcomes (longer time to tumor progression and longer overall survival).